On May 20, Indian Markets tumble on rising bond yields and fears of covid resurgence.
As per the company’s filing with the bourses, Biocon Biologics has developed and manufactured this injection while Yoshindo Inc.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
The revenue for the quarter was ₹442 crore, up 20% from ₹368.3 crore in Q4 FY24.
Nearly 66% of full year hybrid fund flows in FY25 came in the first half of the financial year
The company also said that its board has recommended a final dividend of ₹1.5 per equity share for the FY25.
April 2025 core sector growth was the lowest in 8 months as oil and fertilizers disappointed
The Board of Directors of Texmaco has recommended a final dividend of ₹0.75 per equity share of face value of ₹1 (i.e. 75%) for the fiscal year ending March 31, 2025.
The issue may be done through public offers or private placements. This subject to market conditions, and regulatory approvals, stated the public lender.
Here are some of the stocks that may see significant price movement today.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
